Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04324749
Other study ID # 002501
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 18, 2019
Est. completion date June 30, 2020

Study information

Verified date July 2021
Source University of Barcelona
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Nuts have a prebiotic effect mainly due to their content of fiber and polyphenols, which provide substrates for the human gut microbiota. It is known that prebiotic substances are metabolized by microbiota generating postbiotics substances (products or metabolic by-products secreted by live bacteria or released after bacterial lysis). These products may improve host health and partly explain the health benefits of nut consumption. However, no study has been performed about the pre- and postbiotic effects of peanut and peanut butter consumption. Therefore, researchers propose a new interventional study to assess the impact of daily peanut and peanut butter intake on the organism, evaluating the pre- and postbiotic effects. The metabolome data generated will be correlated with the beneficial effects and cognitive skills. The final aim of this work is to spread a message of the health benefits of peanut consumption for the general population.


Description:

To evaluate the possible changes in microbiota and cognitive skills after consumption of roasted peanuts and peanut butter, a three-arm parallel-group randomized, and controlled study is being carried out. Ninety healthy college students were enrolled, according to the sample size estimated. Blood, urine, feces and saliva are being drawing at baseline, 3 and 6 months. Peripheral blood mononuclear cells are being extracted to evaluate the metabolic changes caused by the proposed nutritional interventions. To assess diet and physical activity a 151-items food frequency questionnaire plus a 7-day dietary record and a validated questionnaire Minnesota are being used. To determinate the effects of the intervention on body composition and vascular risk factors, anthropometric, biochemical and clinical measurements are being collected. Possible changes in cognitive skills will be determined from a validated cognitive questionnaire (WAIS-IV, Wechsler Memory Scale-IV (WMS-IV), COPE and HAD). To evaluate inflammation and metabolic status before and after intervention, levels of hormones and signaling molecules will be analyzed in blood samples. The effect of roasted peanut and peanut butter consumption on microbiota will be assayed through identification and quantification of polyphenols and short-chain fatty acids in biological samples, as well as the gut microbiota characterization from DNA extraction.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date June 30, 2020
Est. primary completion date December 18, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 32 Years
Eligibility Inclusion Criteria: - Healthy college students (aged between 18 and 32 years) Exclusion Criteria: - History of pathological conditions (cardiovascular diseases, cancer, diabetes and other chronic diseases) - Alteration of clinical parameters (cholesterol, triglycerides and other markers) - Peanut allergy or intolerance - Use of dietary supplements or drugs - Unusual dietary habits - Usual consumption of wine and grapes - Alcohol intake (>30 g/day in males and >20 g/day in females) - Smokers - BMI <18.5 or >25

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Roasted peanuts (group A)
After 2 weeks following a peanut-free diet, the participants of this group consume 25 g/ day of whole skin roasted peanuts (RP) within the habitual diet during 6 months.
Peanut butter (group B)
After 2 weeks following a peanut-free diet, the participants of this group consume 2 tbsp/ day (32 g/ day) of peanut butter (PB) within the habitual diet during 6 months.
Control (group C)
After 2 weeks following a peanut-free diet, the participants of this group consume 2 tbsp/ day (32 g/ day) of control supplement (containing the same proportion of macronutrients as peanuts and peanut butter) within the habitual diet during 6 months.

Locations

Country Name City State
Spain Department of Nutrition, Food Sciences and Gastronomy. School of Farmacy and Food Sciences. University of Barcelona. Barcelona

Sponsors (2)

Lead Sponsor Collaborator
University of Barcelona The Peanut Institute

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in the polyphenols and their metabolites after a daily intake of peanuts and peanut butter in biological samples of healthy college students Identification and quantification of polyphenols will be determined using a high performance liquid chromatography-high resolution mass spectrometry (HPLC-HRMS) method (Sasot et al., 2017) and quantified by ultra high-performance liquid chromatography coupled with triple quadrupole mass spectrometry (UHPLC-QqQ-MS/MS) methodology (Martínez-Huélamo et al., 2015). Baseline and after completed the intervention (6 months)
Primary Changes in the short-chain fatty acids after a daily intake of peanuts and peanut butter in biological samples of healthy college students After acidifying the fecal samples with formic acid, a quantification of short-chain fatty acids will be performed using gas chromatography by direct injection according to previously described methodology (Zhao et al., 2006). Baseline and after completed the intervention (6 months)
Primary Changes in the gut microbiota after a daily intake of peanuts and peanut butter in fecal samples of healthy college students Fecal samples will be collected by the volunteers using a system for easy self-collection and stabilization of microbial DNA for gut microbiome profiling (OMNIgene - GUT). The genomic DNA will be extracted from fecal samples using the DNeasy PowerSoil Kit. Then, the 16s metagenomic analysis will be performed. Baseline and after completed the intervention (6 months)
Primary Changes in the intelligence and cognitive ability in healthy college students after a daily intake of peanuts and peanut butter To measure intelligence and cognitive ability, the Wechsler Adult Intelligence Scale IV (WAIS IV) will be used. Baseline and after completed the intervention (6 months)
Primary Changes in the memory function in healthy college students after a daily intake of peanuts and peanut butter To measure memory function, the Wechsler Memory Scale IV (WSM IV) will be used. Baseline and after completed the intervention (6 months)
Primary Changes in language and executive function in healthy college students after a daily intake of peanuts and peanut butter To measure language and executive function, lexical fluency tests will be used. Baseline and after completed the intervention (6 months)
Primary Changes in cope to stressful situations in healthy college students after a daily intake of peanuts and peanut butter The 48-items Coping Orientation to Problems Experienced questionnaire (COPE-48) will be performed to assay how healthy college students cope with highly demanding situations demanding situations of healthy college students. Baseline and after completed the intervention (6 months)
Primary Changes in levels of anxiety and depression in healthy college students after a daily intake of peanuts and peanut butter To measure the levels of anxiety and depression of healthy college students the Hospital Anxiety and Depression Scale (HAD) will be used. Baseline and after completed the intervention (6 months)
Secondary Changes in body mass index after a daily intake of peanuts and peanut butter in healthy college students Body mass index (kg/m^2) are calculated after measure weight (kg) and height (meter). Baseline, 3 months and after completed the intervention (6 months)
Secondary Changes in waist-to-hip ratio after a daily intake of peanuts and peanut butter in healthy college students To evaluate waist-to-hip ratio, waist and hip circumferences (cm) are measured in triplicate Baseline, 3 months and after completed the intervention (6 months)
Secondary Changes in percentage of body fat after a daily intake of peanuts and peanut butter in healthy college students Total adiposity are measured by bioelectrical impedance (percentage of fat). Baseline, 3 months and after completed the intervention (6 months)
Secondary Changes in blood pressure after a daily intake of peanuts and peanut butter in healthy college students Systolic and diastolic blood pressure (mmHg) are measured with an automatic blood pressure monitor in triplicate. Baseline, 3 months and after completed the intervention (6 months)
Secondary Changes in heart rate after a daily intake of peanuts and peanut butter in healthy college students Heart rate (bpm) is measured with an automatic monitor in triplicate. Baseline, 3 months and after completed the intervention (6 months)
Secondary Changes in lipidic profile after a daily intake of peanuts and peanut butter in healthy college students Total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides (mg/dL) are measured by molecular absorption spectrometry. Baseline, 3 months and after completed the intervention (6 months)
Secondary Changes in glucose after a daily intake of peanuts and peanut butter in healthy college students Glucose (mg/dL) is measured by molecular absorption spectrometry. Baseline, 3 months and after completed the intervention (6 months)
Secondary Changes in cortisol after a daily intake of peanuts and peanut butter in healthy college Cortisol (nmol/l) is measured by immunochemiluminescence Baseline, 3 months and after completed the intervention (6 months)
Secondary Changes in pro- and anti-inflammatory biomarkers after a daily intake of peanuts and peanut butter in healthy college Cytokines (pg/mL), tumor necrosis factor a (TNF-a) (pg/mL) and C-reactive protein (CRP) (mg/dL) will be assayed by immunoenzymatic methods. Baseline and after completed the intervention (6 months)
Secondary Changes in nutrients and energy intake after regular peanut and peanut butter consumption in healthy college Dietary changes are evaluated with a 151-item semi-quantitative food frequency questionnaire (Fernández-Ballart et al., 2010). In addition, a 7-day food recall on the day of the intervention are used to validated this results. These were analyzed using a software called Programa de Càlcul Nutricional Professional (PCN Pro). Baseline and after completed the intervention (6 months)
Secondary Changes in physical activity after regular peanut and peanut butter consumption in healthy college Physical activity is measured by the validated Spanish version of the Minnesota Leisure-Time Physical Activity Questionnaire (Elosua et al., 1994). Baseline and after completed the intervention (6 months)
See also
  Status Clinical Trial Phase
Completed NCT05712005 - Cognitive Testing in Diverse Populations to Further the Objective and Clinical Understanding of Cognivue Study
Completed NCT05343208 - Effectiveness of Online Therapy to Prevent Burnout N/A
Active, not recruiting NCT05143294 - Conectar Jugando: Board Games in Elementary Classrooms (6-12 Years Old) to Improve Executive Functions N/A
Completed NCT05267730 - Conectar Jugando: Board Games in Rural Elementary Classrooms (6-12 Years Old) to Improve Executive Functions N/A
Completed NCT03987477 - Online Intervention to Modify Interpretation Biases in Depression N/A
Completed NCT03695003 - Cognitive Effects of Sage in Healthy Humans N/A
Completed NCT05075850 - Multicenter Sub-study for LAANTERN Registry NCT02392078 That Will Include Comprehensive Neuropsychological Assessment Data Collection
Recruiting NCT05273996 - Predictors of Cognitive Outcomes in Geriatric Depression Phase 4
Completed NCT03674281 - The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery System N/A
Completed NCT03689348 - Acute and Chronic Effects of Avena Sativa on Cognition and Stress N/A
Active, not recruiting NCT05229705 - Exercise in Older Adults at Risk for Type 2 Diabetes N/A
Suspended NCT05001789 - Cognitive Functioning in Opioid Use Disorder N/A
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Recruiting NCT05014399 - Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Completed NCT03657537 - Effects of Ketone Bodies on Cognition in Type 2 Diabetes Phase 1
Completed NCT05543811 - The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology N/A
Recruiting NCT05699226 - Amplitude Titration to Improve ECT Clinical Outcomes N/A
Recruiting NCT05026541 - Resilience to Sleep Deprivation and Changes in Sleep Architecture in Shoonya Meditators N/A
Active, not recruiting NCT03255499 - Efficacy of the MovinCog Intervention in Children N/A
Not yet recruiting NCT06252376 - Effects of Blood Pressure on Cognition and Cerebral Hemodynamics in PD N/A